Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations - Isomorphic Labs
Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations
Source: isomorphiclabs.com
Coding excursions
Anonymity with encryption At Outcomes Engine we are working on techniques to gather data from learners, analyse the data, and share the data whilst maintaining anonymity. I was involved in some work in my previous company (pharmaceutical) with the security of personal data - in our case it was data...
Pharma recommends five priorities for future pandemic preparedness and response - IFPMA
As the global architecture for pandemic preparedness and response is discussed, IFPMA shares practical solutions and recommends focussing on five priorities.
Source: ifpma.org
Biopharma futures
I've been looking at a few industry reports on the future of biopharma as part of a course I'm on with INSEAD Business School on Business Strategy and Financial Performance. I thought I'd share some of my ramblings on Biopharma Futures. Expectations are high Pharmaceutical
companies are operating...
Source: agnate.co.uk
What does the future of work look like for pharma?
The COVID-19 pandemic has accelerated changes to our working world. What does this mean for pharma, and what must the industry do to keep pace? PwC - future of work for pharma costs - pressures on efficienct, increasing R&D costs sustainability and societal impact - pressure on companies to address...
Source: pwc.co.uk
The 10 Trends Shaping the Future of Pharma - The Medical Futurist
The medical community gradually acknowledges digital health but doesn't embrace it entirely. Familiarize yourself with the future of pharma! Medical Futurist 10 trends shaping the future of pharma Patients on advisory boards - to better know the exact needs Digital health strategy 'around the pill'...
Source: medicalfuturist.com
Biopharma 2020: A landmark year and a reset for the future
Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of purpose in the years ahead? McKinsey biopharma 2020 3 Overarching trends Operating under a spotlight - expectation of innovationNavigating protracted economic uncertainty -...
Source: mckinsey.com
The future of biopharma
Shifts in how diseases are diagnosed and prevented, custom treatments, curative therapies, digital therapeutics, and precision intervention could upend current business models in biopharma. Deloitte's Five forces to 2040 Prevention and early detection Customized treatments - interventions for very...
Source: deloitte.com
Factors affecting the uptake of new medicines: a systematic literature review - BMC Health Services Research Lublóy, Ágnes.
"This systematic literature review has provided insights into the factors that affect new drug uptake—primarily, doctors’ scientific orientation, prescribing habits, exposure to pharmaceutical marketing, and interpersonal communication." "Background The successful diffusion of new drugs is crucial...
Source: biomedcentral.com
The leader's brain: Neuroscience in the workplace
The brain rarely fires on all cylinders even at the best of times - what more during a pandemic?
Source: reuters.com
Outgoing U.N. aid chief slams G7 for failing on vaccine plan
Outgoing U.N. aid chief Mark Lowcock slammed the Group of Seven wealthy nations on Monday for failing to come up with a plan to vaccinate the world against COVID-19, describing the G7 pledge to provide 1 billion doses over the next year as a "small step."
Source: reuters.com
Validation of Claims-Based Algorithms to Identify Patients with Psoriasis - PubMed Pharmacoepidemiology and drug safety.
Claims-based algorithms based on a combination of PsO diagnosis codes and dispensing for PsO-specific treatments had a moderate-to-high PPV. These algorithms can serve as a useful tool to identify patients with PsO in future real-world data pharmacoepidemiologic studies. This article is protected by...
Source: nih.gov
Quantum computing and pharmaceutical research
"Theoretically, quantum computers can prove more powerful than any supercomputer. And recent moves from computer giants such as Google and pharmaceutical titans such as Roche now suggest drug discovery might prove to be quantum computing’s first killer app." In January this year Boehringer-Ingelheim...
Source: ieee.org
The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East
The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East - PubMed: There is an urgent unmet need for comprehensive clinical guidelines on the management of patients with plaque psoriasis in Africa and the Middle East. Region-specific studies...
Source: nih.gov
Pharma
Pharma’s pivotal role in social determinants of health: Pharma manufacturers have a pivotal role to play in precision population health through strategic data collection, analysis, and biopsychosocial and algorithmic interventions to address SDOH.
Source: informaconnect.com
Imperial College's COVID-19 modelling
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. "We show that in the UK and US context, suppression will minimally require a combination of social distancing of the entire population, home isolation of cases and household quarantine of their...
Source: imperial.ac.uk
Coronavirus COVID-19 SARS-CoV-2 information
A collection of information sources for COVID-19. The NHS 111 online COVID-19 service. The first point of call for someone in the UK who thinks they have symptoms or have been exposed whilst travelling. The NHS Coronavirus COVID-19 information webpage. UK Government's Coronavirus action plan. Public...
UCL cancer policy update
“Because of the complexity of delivering better cancer care and the dynamics of NHS funding and introducing better practices in the health service there is a strong case for developing new cancer strategies for all the UK nations for the 2020s. Britain could also benefit from leading an independent...
Source: ucl.ac.uk
Eisai launches a digital health solution on Amazon Alexa for children with a rare form of epilepsy - Lennox-Gastaut Syndrome.
It marks the first time Pharmaceutical company Eisai has moved beyond medications and into digital health. The company’s Amazon Alexa skill – Ella the Jellyfish – has been developed for children with Lennox-Gastaut Syndrome (LGS) and was created with input from patients, their families and caregivers.
Source: epmmagazine.com
Publication bias is a challenge in science and a criticism of the influence of industry.
Publication bias is a challenge in science and a criticism of the influence of industry. In the domain of biosciences and drug development more accountability (e.g. the FDAAA 2007), editorial and peer-review training (as suggested by the Cochrane Collaboration), and statistical techniques (as championed...
RSS feed